Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDMO
Pharma
Lonza hints at CDMO rebound as it reaffirms 2024 guidance
With a new CEO waiting in the wings, Lonza is attempting to reassure the market that a CDMO industry stabilization is playing out.
Fraiser Kansteiner
May 14, 2024 10:22am
WuXi AppTec refutes claim of secret IP transfer in letter to DOD
May 13, 2024 3:00pm
AGC plots around 100 layoffs amid tough business environment
May 10, 2024 11:40am
New bill sets decoupling deadline for industry's work with WuXi
May 10, 2024 11:30am
Takeda, Lilly-Innovent, BIO-China—Fierce Pharma Asia
May 10, 2024 9:30am
BIO survey finds sudden CDMO decoupling could harm patients
May 9, 2024 10:00am